GSKNEUTRAL

GSK EV/EBITDA Analysis

10.5x

Updated 299h ago·SEC filings & market data

Key Takeaway

At 10.5x, GSK trades at 10.5 times its enterprise value (total company value including debt) relative to EBITDA (operating earnings before interest, taxes, depreciation, and amortization) — essentially, the market pays 10.5 years of operating cash flow for the whole business.

Sector Performance

34th percentile

GSK

10.5x

Sector Median

13.6x

Sector Avg

-62.3x

Prior Period

10.9x(Aug 2026)

↑ Improving

📊

Deep Analysis

This is below the sector median of 13.5x, placing GSK at the 34th percentile among sector peers, meaning about two-thirds of peers trade at higher multiples. The metric’s year-over-year change is not available, but quarter-over-quarter it fell 3.7%, from 10.9x to 10.5x. The combination of a below-median level and a recent quarterly decline points to a valuation that is becoming less expensive relative to the sector, which could signal either a value opportunity or reflected business concerns. This metric supports the overall NEUTRAL verdict: the lower multiple is notable but not extreme enough to shift the view toward bullish or bearish.

Frequently Asked Questions

What does the EV/EBITDA tell investors about GSK?

A valuation multiple preferred by analysts for capital-intensive or leveraged businesses. Useful for cross-sector comparisons where earnings can be distorted by debt.

How is the EV/EBITDA calculated?

EV/EBITDA is calculated as: Enterprise Value / EBITDA.

Who are GSK's closest peers by EV/EBITDA?

The closest peers by EV/EBITDA include: FLNC (-22.5x), EVGO (-22.6x), LSPD (-26.9x), BRZE (-29.6x), RBLX (-31.4x).

📚

Learn More About EV/EBITDA

EV/EBITDA Explained: The Valuation Metric Pro Investors Actually Use

Learn what EV/EBITDA is, why it beats P/E for capital-heavy companies, typical sector ranges, and key limitations every serious investor should know.

The Formula

Enterprise Value / EBITDA

Why It Matters

A valuation multiple preferred by analysts for capital-intensive or leveraged businesses. Useful for cross-sector comparisons where earnings can be distorted by debt.